Two new oral antivirals for covid-19: ▼molnupiravir and ▼nirmatrelvir plus ritonavir | Drug and Therapeutics Bulletin

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Browse

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

DTB drug review

Two new oral antivirals for covid-19: ▼molnupiravir and ▼nirmatrelvir plus ritonavir

Online download statistics by month:

Online download statistics by month: April 2022 to March 2024

	Abstract	Full	Pdf
Apr 2022	496	497	98
May 2022	1255	1263	284
Jun 2022	779	785	151
Jul 2022	915	924	404
Aug 2022	539	543	357
Sep 2022	431	436	102
Oct 2022	332	336	104
Nov 2022	352	352	137
Dec 2022	332	335	88
Jan 2023	300	301	109
Feb 2023	199	199	82
Mar 2023	292	293	114
Apr 2023	353	261	51
May 2023	585	6	18
Jun 2023	373	6	6
Jul 2023	430	1	3
Aug 2023	317	3	4
Sep 2023	270	4	6
Oct 2023	252	1	1
Nov 2023	1030	3	5
Dec 2023	189	9	3
Jan 2024	103	14	2
Feb 2024	86	3	2
Mar 2024	129	3	3
Total	10339	6578	2134